208 related articles for article (PubMed ID: 18706401)
1. B-type natriuretic peptide in acute pulmonary embolism.
Kaczyńska A; Kostrubiec M; Ciurzyński M; Pruszczyk P
Clin Chim Acta; 2008 Dec; 398(1-2):1-4. PubMed ID: 18706401
[TBL] [Abstract][Full Text] [Related]
2. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
Kaczyñska A; Pelsers MM; Bochowicz A; Kostrubiec M; Glatz JF; Pruszczyk P
Clin Chim Acta; 2006 Sep; 371(1-2):117-23. PubMed ID: 16698008
[TBL] [Abstract][Full Text] [Related]
3. Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death.
Kostrubiec M; Pruszczyk P; Kaczynska A; Kucher N
Clin Chim Acta; 2007 Jul; 382(1-2):124-8. PubMed ID: 17507005
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis.
Lega JC; Lacasse Y; Lakhal L; Provencher S
Thorax; 2009 Oct; 64(10):869-75. PubMed ID: 19525265
[TBL] [Abstract][Full Text] [Related]
5. [Biohumoral markers and right ventricular dysfunction in acute pulmonary embolism: the answer to thrombolytic therapy].
Enea I; Ceparano G; Mazzarella G; Di Sarno R; Cangiano G; Busino CA
Ital Heart J Suppl; 2004 Jan; 5(1):29-35. PubMed ID: 15253142
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of acute pulmonary embolism.
Kucher N; Goldhaber SZ
Semin Thromb Hemost; 2006 Nov; 32(8):838-47. PubMed ID: 17171598
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
8. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.
Kittleson MM; Skojec DV; Wittstein IS; Champion HC; Judge DP; Barouch LA; Halushka M; Hare JM; Kasper EK; Russell SD
J Heart Lung Transplant; 2009 Jul; 28(7):704-9. PubMed ID: 19560699
[TBL] [Abstract][Full Text] [Related]
9. Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.
Ates H; Ates I; Kundi H; Yilmaz FM
Herz; 2017 Dec; 42(8):758-765. PubMed ID: 27966013
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism.
Pieralli F; Olivotto I; Vanni S; Conti A; Camaiti A; Targioni G; Grifoni S; Berni G
Am J Cardiol; 2006 May; 97(9):1386-90. PubMed ID: 16635617
[TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism.
Pruszczyk P; Kostrubiec M; Bochowicz A; Styczyński G; Szulc M; Kurzyna M; Fijałkowska A; Kuch-Wocial A; Chlewicka I; Torbicki A
Eur Respir J; 2003 Oct; 22(4):649-53. PubMed ID: 14582919
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of NT-proBNP in assessment of right ventricular function in children after tetralogy of Fallot correction - a preliminary study.
Pietrzak R; Werner B
Kardiol Pol; 2009 Apr; 67(4):378-83. PubMed ID: 19492250
[TBL] [Abstract][Full Text] [Related]
14. Pro-B-type natriuretic peptide as a marker of pulmonary embolism in pregnancy: a case report.
Franz MB; Guenthner-Biller MM; Kainer F; Schiessl B
Arch Gynecol Obstet; 2008 May; 277(5):439-40. PubMed ID: 18293006
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptides: physiologic and analytic considerations.
Omland T; Hagve TA
Heart Fail Clin; 2009 Oct; 5(4):471-87. PubMed ID: 19631173
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of serum cardiac biomarkers for right ventricular dysfunction in non-high-risk patients with acute pulmonary thromboembolism].
Liu FF; Gong JN; Jiang Y; Kuang TG; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):847-852. PubMed ID: 30423626
[No Abstract] [Full Text] [Related]
17. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
18. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction.
Pruszczyk P
J Card Fail; 2005 Jun; 11(5 Suppl):S65-9. PubMed ID: 15948104
[TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
